CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 45 of 48

Rheumatology (Oxford)

Briefs 1,761–1,800 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Association of mycophenolate and azathioprine use with cognitive function in systemic lupus

    Cohort studyLupus & APS

  2. Rheumatology (Oxford)

    Whole grain consumption and risk of radiographic knee osteoarthritis: a prospective study from the Osteoarthritis Initiative

    Cohort studyOsteoarthritis

  3. Rheumatology (Oxford)

    Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study

    Randomized controlled trialSpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease

    Cohort studyMyositis

  5. Rheumatology (Oxford)

    Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms

    Mechanistic studyMyositis

  6. Rheumatology (Oxford)

    Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis

    Meta-analysisRA

  7. Rheumatology (Oxford)

    An ankylosing spondylitis risk variant alters osteoclast differentiation

    Case-control studySpondyloarthritis & PsA

  8. Rheumatology (Oxford)

    Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status

    Cohort studyAcross diseases

  9. Rheumatology (Oxford)

    Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout

    Cross-sectional studyGout & crystals

  10. Rheumatology (Oxford)

    Down-regulated FcγRII expression on plasma cells is associated with the disease activity of ANCA-associated vasculitis

    Cross-sectional studyVasculitis & PMR

  11. Rheumatology (Oxford)

    Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial

    Secondary analysisSystemic sclerosis

  12. Rheumatology (Oxford)

    Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis

    Cohort studyPediatric

  13. Rheumatology (Oxford)

    Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  14. Rheumatology (Oxford)

    Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population

    Cohort studyVasculitis & PMR

  15. Rheumatology (Oxford)

    Treating spondyloarthritis early: does it matter? Results from a systematic literature review

    Research articleSpondyloarthritis & PsA

  16. Rheumatology (Oxford)

    Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT

    Cross-sectional studySpondyloarthritis & PsA

  17. Rheumatology (Oxford)

    Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

    Cohort studySystemic sclerosis

  18. Rheumatology (Oxford)

    SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis

    Mechanistic studyLupus & APS

  19. Rheumatology (Oxford)

    Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis

    Cohort studySystemic sclerosis

  20. Rheumatology (Oxford)

    The influence of age on the prevalence of inflammatory and structural MRI lesions in the sacroiliac joints of patients with and without axial spondyloarthritis

    Cohort studySpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients

    Cohort studySystemic sclerosis

  22. Rheumatology (Oxford)

    COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort

    Cohort studyAcross diseases

  23. Rheumatology (Oxford)

    Immune checkpoint inhibitor–induced arthralgia is tightly associated with improved overall survival in cancer patients

    Meta-analysis

  24. Rheumatology (Oxford)

    Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania

    Cross-sectional studyRA

  25. Rheumatology (Oxford)

    Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study

    Secondary analysisRA

  26. Rheumatology (Oxford)

    Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

    Cohort studyGout & crystals

  27. Rheumatology (Oxford)

    Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses

    Cohort studySjögren's & overlap

  28. Rheumatology (Oxford)

    Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis

    Mechanistic studySystemic sclerosis

  29. Rheumatology (Oxford)

    Predicting lymphoma in Sjögren’s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording

    Case-control studySjögren's & overlap

  30. Rheumatology (Oxford)

    A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients

    Cross-sectional studyRA

  31. Rheumatology (Oxford)

    Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis

    Cohort studyRA

  32. Rheumatology (Oxford)

    Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression

    Cohort studySystemic sclerosis

  33. Rheumatology (Oxford)

    Allelic expression imbalance in articular cartilage and subchondral bone refined genome-wide association signals in osteoarthritis

    Mechanistic studyOsteoarthritis

  34. Rheumatology (Oxford)

    A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials

    Cohort studySystemic sclerosis

  35. Rheumatology (Oxford)

    Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: apost hocanalysis of the TULIP-1 and TULIP-2 trials

    Secondary analysisLupus & APS

  36. Rheumatology (Oxford)

    Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE

    Secondary analysisRA

  37. Rheumatology (Oxford)

    Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis

    Meta-analysisAcross diseases

  38. Rheumatology (Oxford)

    Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study

    Cross-sectional studyPediatric

  39. Rheumatology (Oxford)

    Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis

    Cohort studyRA

  40. Rheumatology (Oxford)

    In patients with acute mono/oligoarthritis, a targeted ultrasound scanning protocol shows great accuracy for the diagnosis of gout and CPPD

    Diagnostic or prognostic studyGout & crystals

All 1,905 Briefs in ExploreShowing Briefs 1,761–1,800 of 1,905, newest first